The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery

Rizwan Ahmed, Joseph Lopez, Sunjae Bae, Allan B Massie, Eric K. Chow, Karan Chopra, Babak J. Orandi, Bonnie E. Lonze, James W. May, Justin Michael Sacks, Dorry Segev

Research output: Contribution to journalArticle

Abstract

Background The Physician Payments Sunshine Act (PSSA) is a government initiative that requires all biomedical companies to publicly disclose payments to physicians through the Open Payments Program (OPP). The goal of this study was to use the OPP database and evaluate all nonresearch-related financial transactions between plastic surgeons and biomedical companies. Methods Using the first wave of OPP data published on September 30, 2014, we studied the national distribution of industry payments made to plastic surgeons during a 5-month period. We explored whether a plastic surgeon's scientific productivity (as determined by their h-index), practice setting (private versus academic), geographic location, and subspecialty were associated with payment amount. Results Plastic surgeons (N = 4195) received a total of US $5,278,613. The median (IQR) payment to a plastic surgeon was US $115 (US $35-298); mean, US $158. The largest payment to an individual was US $341,384. The largest payment category was non-CEP speaker fees (US $1,709,930) followed by consulting fees (US $1,403,770). Plastic surgeons in private practice received higher payments per surgeon compared with surgeons in academic practice (median [IQR], US $165 [US $81-$441] vs median [IQR], US $112 [US $33-$291], rank-sum P < 0.001). Among academic plastic surgeons, a higher h-index was associated with 77% greater chance of receiving at least US $1000 in total payments (RR/10 unit h-index increase = 1.47 1.772.11, P < 0.001). This association was not seen among plastic surgeons in private practice (RR = 0.89 1.091.32, P < 0.4). Conclusions Plastic surgeons in private practice receive higher payments from industry. Among academic plastic surgeons, higher payments were associated with higher h-indices.

Original languageEnglish (US)
Pages (from-to)315-323
Number of pages9
JournalAnnals of Plastic Surgery
Volume78
Issue number3
DOIs
StatePublished - Mar 1 2017

Fingerprint

Sunlight
Plastic Surgery
Physicians
Private Practice
Fees and Charges
Surgeons
Industry
Geographic Locations
Databases

Keywords

  • academic productivity
  • bibliometrics
  • h-index
  • industry physician conflicts-of-interest
  • Open payments program
  • physician payments sunshine act
  • plastic surgery

ASJC Scopus subject areas

  • Surgery

Cite this

The Dawn of Transparency : Insights from the Physician Payment Sunshine Act in Plastic Surgery. / Ahmed, Rizwan; Lopez, Joseph; Bae, Sunjae; Massie, Allan B; Chow, Eric K.; Chopra, Karan; Orandi, Babak J.; Lonze, Bonnie E.; May, James W.; Sacks, Justin Michael; Segev, Dorry.

In: Annals of Plastic Surgery, Vol. 78, No. 3, 01.03.2017, p. 315-323.

Research output: Contribution to journalArticle

Ahmed, Rizwan ; Lopez, Joseph ; Bae, Sunjae ; Massie, Allan B ; Chow, Eric K. ; Chopra, Karan ; Orandi, Babak J. ; Lonze, Bonnie E. ; May, James W. ; Sacks, Justin Michael ; Segev, Dorry. / The Dawn of Transparency : Insights from the Physician Payment Sunshine Act in Plastic Surgery. In: Annals of Plastic Surgery. 2017 ; Vol. 78, No. 3. pp. 315-323.
@article{9c30b5a034204b8eacff4fc0df535ea3,
title = "The Dawn of Transparency: Insights from the Physician Payment Sunshine Act in Plastic Surgery",
abstract = "Background The Physician Payments Sunshine Act (PSSA) is a government initiative that requires all biomedical companies to publicly disclose payments to physicians through the Open Payments Program (OPP). The goal of this study was to use the OPP database and evaluate all nonresearch-related financial transactions between plastic surgeons and biomedical companies. Methods Using the first wave of OPP data published on September 30, 2014, we studied the national distribution of industry payments made to plastic surgeons during a 5-month period. We explored whether a plastic surgeon's scientific productivity (as determined by their h-index), practice setting (private versus academic), geographic location, and subspecialty were associated with payment amount. Results Plastic surgeons (N = 4195) received a total of US $5,278,613. The median (IQR) payment to a plastic surgeon was US $115 (US $35-298); mean, US $158. The largest payment to an individual was US $341,384. The largest payment category was non-CEP speaker fees (US $1,709,930) followed by consulting fees (US $1,403,770). Plastic surgeons in private practice received higher payments per surgeon compared with surgeons in academic practice (median [IQR], US $165 [US $81-$441] vs median [IQR], US $112 [US $33-$291], rank-sum P < 0.001). Among academic plastic surgeons, a higher h-index was associated with 77{\%} greater chance of receiving at least US $1000 in total payments (RR/10 unit h-index increase = 1.47 1.772.11, P < 0.001). This association was not seen among plastic surgeons in private practice (RR = 0.89 1.091.32, P < 0.4). Conclusions Plastic surgeons in private practice receive higher payments from industry. Among academic plastic surgeons, higher payments were associated with higher h-indices.",
keywords = "academic productivity, bibliometrics, h-index, industry physician conflicts-of-interest, Open payments program, physician payments sunshine act, plastic surgery",
author = "Rizwan Ahmed and Joseph Lopez and Sunjae Bae and Massie, {Allan B} and Chow, {Eric K.} and Karan Chopra and Orandi, {Babak J.} and Lonze, {Bonnie E.} and May, {James W.} and Sacks, {Justin Michael} and Dorry Segev",
year = "2017",
month = "3",
day = "1",
doi = "10.1097/SAP.0000000000000874",
language = "English (US)",
volume = "78",
pages = "315--323",
journal = "Annals of Plastic Surgery",
issn = "0148-7043",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - The Dawn of Transparency

T2 - Insights from the Physician Payment Sunshine Act in Plastic Surgery

AU - Ahmed, Rizwan

AU - Lopez, Joseph

AU - Bae, Sunjae

AU - Massie, Allan B

AU - Chow, Eric K.

AU - Chopra, Karan

AU - Orandi, Babak J.

AU - Lonze, Bonnie E.

AU - May, James W.

AU - Sacks, Justin Michael

AU - Segev, Dorry

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background The Physician Payments Sunshine Act (PSSA) is a government initiative that requires all biomedical companies to publicly disclose payments to physicians through the Open Payments Program (OPP). The goal of this study was to use the OPP database and evaluate all nonresearch-related financial transactions between plastic surgeons and biomedical companies. Methods Using the first wave of OPP data published on September 30, 2014, we studied the national distribution of industry payments made to plastic surgeons during a 5-month period. We explored whether a plastic surgeon's scientific productivity (as determined by their h-index), practice setting (private versus academic), geographic location, and subspecialty were associated with payment amount. Results Plastic surgeons (N = 4195) received a total of US $5,278,613. The median (IQR) payment to a plastic surgeon was US $115 (US $35-298); mean, US $158. The largest payment to an individual was US $341,384. The largest payment category was non-CEP speaker fees (US $1,709,930) followed by consulting fees (US $1,403,770). Plastic surgeons in private practice received higher payments per surgeon compared with surgeons in academic practice (median [IQR], US $165 [US $81-$441] vs median [IQR], US $112 [US $33-$291], rank-sum P < 0.001). Among academic plastic surgeons, a higher h-index was associated with 77% greater chance of receiving at least US $1000 in total payments (RR/10 unit h-index increase = 1.47 1.772.11, P < 0.001). This association was not seen among plastic surgeons in private practice (RR = 0.89 1.091.32, P < 0.4). Conclusions Plastic surgeons in private practice receive higher payments from industry. Among academic plastic surgeons, higher payments were associated with higher h-indices.

AB - Background The Physician Payments Sunshine Act (PSSA) is a government initiative that requires all biomedical companies to publicly disclose payments to physicians through the Open Payments Program (OPP). The goal of this study was to use the OPP database and evaluate all nonresearch-related financial transactions between plastic surgeons and biomedical companies. Methods Using the first wave of OPP data published on September 30, 2014, we studied the national distribution of industry payments made to plastic surgeons during a 5-month period. We explored whether a plastic surgeon's scientific productivity (as determined by their h-index), practice setting (private versus academic), geographic location, and subspecialty were associated with payment amount. Results Plastic surgeons (N = 4195) received a total of US $5,278,613. The median (IQR) payment to a plastic surgeon was US $115 (US $35-298); mean, US $158. The largest payment to an individual was US $341,384. The largest payment category was non-CEP speaker fees (US $1,709,930) followed by consulting fees (US $1,403,770). Plastic surgeons in private practice received higher payments per surgeon compared with surgeons in academic practice (median [IQR], US $165 [US $81-$441] vs median [IQR], US $112 [US $33-$291], rank-sum P < 0.001). Among academic plastic surgeons, a higher h-index was associated with 77% greater chance of receiving at least US $1000 in total payments (RR/10 unit h-index increase = 1.47 1.772.11, P < 0.001). This association was not seen among plastic surgeons in private practice (RR = 0.89 1.091.32, P < 0.4). Conclusions Plastic surgeons in private practice receive higher payments from industry. Among academic plastic surgeons, higher payments were associated with higher h-indices.

KW - academic productivity

KW - bibliometrics

KW - h-index

KW - industry physician conflicts-of-interest

KW - Open payments program

KW - physician payments sunshine act

KW - plastic surgery

UR - http://www.scopus.com/inward/record.url?scp=85013151768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013151768&partnerID=8YFLogxK

U2 - 10.1097/SAP.0000000000000874

DO - 10.1097/SAP.0000000000000874

M3 - Article

C2 - 28182596

AN - SCOPUS:85013151768

VL - 78

SP - 315

EP - 323

JO - Annals of Plastic Surgery

JF - Annals of Plastic Surgery

SN - 0148-7043

IS - 3

ER -